RHEUMATOID ARTHRITIS Triple therapy or etanercept after methotrexate failure in RA?

Ronald F. van Vollenhoven, Katerina Chatzidionysiou

Research output: Contribution to journalEditorialAcademicpeer-review

8 Citations (Scopus)

Abstract

Since the 1990s, patients with rheumatoid arthritis have been treated with at least one DMARD. Methotrexate, which is usually the first-line treatment, elicits good or even excellent clinical results in 20-30% of patients-but in most patients it does not. Thus, an important question is what to do after methotrexate failure
Original languageEnglish
Pages (from-to)510-512
JournalNature reviews. Rheumatology
Volume9
Issue number9
DOIs
Publication statusPublished - 2013
Externally publishedYes

Cite this